Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3932889 | 1.00 | DNM1 (0.37) | DNM1TSHRTHRB | |
| SCHEMBL2695420 | 1.00 | DNM1 (0.37) | DNM1TSHRTHRB | |
| SCHEMBL2694434 | 1.00 | DNM1 (0.37) | DNM1TSHRTHRB | |
| SCHEMBL2695539 | 0.98 | DNM1 (0.38) | DNM1TSHRTHRB | |
| SCHEMBL6065603 | 0.98 | DNM1 (0.38) | DNM1TSHRTHRB | |
| SCHEMBL7561743 | 0.98 | DNM1 (0.38) | DNM1TSHRTHRB | |
| SCHEMBL7554291 | 0.96 | DNM1 (0.34) | DNM1 | |
| SCHEMBL134375 | 0.94 | — | — | |
| SCHEMBL29411325 | 0.91 | DNM1 (0.33) | DNM1 | |
| SCHEMBL29396576 | 0.91 | DNM1 (0.35) | DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331753-A1 | Ligand Compound, Organochromium Compound and Catalyst System Comprising the Same | LG CHEM, LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| WO-2022060108-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST SYSTEM COMPRISING SAME | 주식회사 엘지화학 | 2022-03-24 | — | — | WO | disclosed |
| US-9035119-B2 | Oligomerisation of olefinic compounds in the presence of an activated oligomerisation catalyst | SASOL TECHNOLOGY (PTY) LIMITED (ZA) | 2015-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331753-A1 | Ligand Compound, Organochromium Compound and Catalyst System Comprising the Same | ETV6, ESR1, OXER1 | DNM1 1424/4885TSHR 655/4885THRB 2172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.